Confirmed Keynote Speakers and provisional titles
Frederic Auvray, Institute de Recherce en Santé Digestive, INRA, France
Stx Phages and their induction
Bert Devriendt, Laboratory of Immunology, Ghent University Belgium
New oral vaccination strategies based on interaction of
enterotoxigenic E. coli with the intestinal mucosa
Edward Dudley, Director E. coli Reference Center, The Pennsylvania
State University, US
Commensal E. coli that enhance toxin production by E. coli O157:H7
James Fleckenstein, Washington University School of Medicine,
Missouri, US
Remodeling of intestinal epithelial architecture by enterotoxigenic E. coli
Stephanie Ganal-Vonarburg, Department for BioMedical Research,
University of Bern, Switzerland
Role of the maternal macrobiotic in shaping gene expression and
microbiota composition in the offspring intestine
Henk Haagsman, Departement of Infectious Diseases & Immunology,
Utrecht University, The Netherlands
Cathelicidins, host defense peptides against E. coli infections
Katja Brunner , CRCN, INSERM, Center for Pathophysiology of Toulouse
Purpan, Toulouse University, France
T-dependent humoral responses in mucosal sites
Armelle Phalipon, Molecular Microbial Pathogenesis, Institut Pasteur,
France
New insights regarding the interplay between Shigella and human
lymphocytes
Christina Schäffer, Department für NanoBiotechnologie,
BOKU -University of Natural Resources and Life Sciences, Vienna
Austria
Possible roles of glycobiology for establishment and persistence
of bacteria in the host
Åsa Sjöling, Department of Microbiology, Tumor and Cell Biology (MTC)
Karolinska Institute, Sweden
Bile salts and other host factors regulate expression of ETEC virulence genes
Ann-Mari Svennerholm, Sahlgrenska Academy, University of
Ghotenburg, Sweden
Clinical trials of an oral ETEC vaccine, ETVAX, in children in developing countries
and in traveler
Vikram Virdi, VIB-UGent Center for Medical Biotechnology, Belgium
In feed administered non-encapsulated monomeric porcine IgAlike
antibodies produced in yeast as prophylaxis against F4-
mediated colibacillosis in pigs
Weiping Zhang, Department of Pathobiology, University of Illinois
at Urbana-Champaign, US
New strategies in development of vaccines against ETEC
Frederic Auvray, Institute de Recherce en Santé Digestive, INRA, France
Stx Phages and their induction
Bert Devriendt, Laboratory of Immunology, Ghent University Belgium
New oral vaccination strategies based on interaction of
enterotoxigenic E. coli with the intestinal mucosa
Edward Dudley, Director E. coli Reference Center, The Pennsylvania
State University, US
Commensal E. coli that enhance toxin production by E. coli O157:H7
James Fleckenstein, Washington University School of Medicine,
Missouri, US
Remodeling of intestinal epithelial architecture by enterotoxigenic E. coli
Stephanie Ganal-Vonarburg, Department for BioMedical Research,
University of Bern, Switzerland
Role of the maternal macrobiotic in shaping gene expression and
microbiota composition in the offspring intestine
Henk Haagsman, Departement of Infectious Diseases & Immunology,
Utrecht University, The Netherlands
Cathelicidins, host defense peptides against E. coli infections
Katja Brunner , CRCN, INSERM, Center for Pathophysiology of Toulouse
Purpan, Toulouse University, France
T-dependent humoral responses in mucosal sites
Armelle Phalipon, Molecular Microbial Pathogenesis, Institut Pasteur,
France
New insights regarding the interplay between Shigella and human
lymphocytes
Christina Schäffer, Department für NanoBiotechnologie,
BOKU -University of Natural Resources and Life Sciences, Vienna
Austria
Possible roles of glycobiology for establishment and persistence
of bacteria in the host
Åsa Sjöling, Department of Microbiology, Tumor and Cell Biology (MTC)
Karolinska Institute, Sweden
Bile salts and other host factors regulate expression of ETEC virulence genes
Ann-Mari Svennerholm, Sahlgrenska Academy, University of
Ghotenburg, Sweden
Clinical trials of an oral ETEC vaccine, ETVAX, in children in developing countries
and in traveler
Vikram Virdi, VIB-UGent Center for Medical Biotechnology, Belgium
In feed administered non-encapsulated monomeric porcine IgAlike
antibodies produced in yeast as prophylaxis against F4-
mediated colibacillosis in pigs
Weiping Zhang, Department of Pathobiology, University of Illinois
at Urbana-Champaign, US
New strategies in development of vaccines against ETEC